Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01331941
What this trial is testing

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

Who this might be right for
Advanced Solid TumorsKidney DiseaseRenal Impairment
Amgen 35
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Testing effectiveness (Phase 2)Looking for participantsNCT06889649
What this trial is testing

SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC

Who this might be right for
Radiation TherapyTargeted TherapyImmunotherapy+1 more
Peking University First Hospital 30
Not applicableWithdrawnNCT07624578
What this trial is testing

Evaluation of 68Ga-PSMA PET-CT in the Initial Staging of Advanced Renal Cell Carcinomas - A Prospective, Multicentre, Open-label Study

Who this might be right for
Kidney Cancers
Assistance Publique Hopitaux De Marseille
Early research (Phase 1)Study completedNCT00098943
What this trial is testing

NGR-TNF in Treating Patients With Advanced Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck CancerKidney Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 70
Large-scale testing (Phase 3)Looking for participantsNCT06349668
What this trial is testing

Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery

Who this might be right for
Other Specified Disorders of Kidney and UreterBenign Neoplasm of UreterCalculus of Kidney and Ureter+5 more
Hans Bahlmann 220
Early research (Phase 1)Study completedNCT02386826
What this trial is testing

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma MultiformeGliosarcomaColorectal Cancer+1 more
SCRI Development Innovations, LLC 65
Testing effectiveness (Phase 2)Study completedNCT02724878
What this trial is testing

Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced Non-Clear Cell Kidney Cancer
Dana-Farber Cancer Institute 65
Large-scale testing (Phase 3)Study completedNCT00111020
What this trial is testing

Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 2,567
Testing effectiveness (Phase 2)UnknownNCT05879497
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 40
Large-scale testing (Phase 3)Study completedNCT00375674
What this trial is testing

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

Who this might be right for
Kidney Neoplasms
Pfizer 674
Testing effectiveness (Phase 2)Ended earlyNCT03875313
What this trial is testing

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more
Calithera Biosciences, Inc 33
Not applicableUnknownNCT04666220
What this trial is testing

VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma

Who this might be right for
Renal Cell CarcinomaAdrenal Carcinoma
Humanitas Clinical and Research Center 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05148546
What this trial is testing

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer

Who this might be right for
Renal Cell Carcinoma
The Netherlands Cancer Institute 69
Not applicableStudy completedNCT05070637
What this trial is testing

Circulating Tumor Cell Reducing No-touch Nephrectomy

Who this might be right for
Renal Cell CarcinomaCirculating Tumor Cell
Hospital de Santa Maria, Portugal 44
Testing effectiveness (Phase 2)UnknownNCT04631731
What this trial is testing

Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity

Who this might be right for
Lung Cancer, Nonsmall CellRenal Cell CarcinomaMelanoma+4 more
Western Sydney Local Health District 200
Not applicableWithdrawnNCT02307474
What this trial is testing

A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell Carcinoma
Case Comprehensive Cancer Center
Not applicableStudy completedNCT02742597
What this trial is testing

Patient-Centred Innovations for Persons With Multimorbidity - Ontario

Who this might be right for
HypertensionDepressionAnxiety+28 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 175
Testing effectiveness (Phase 2)Active Not RecruitingNCT04258462
What this trial is testing

Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors

Who this might be right for
Benign Kidney NeoplasmKidney NeoplasmRenal Cell Cancer
Zhen Wang, MD 54
Post-approval studies (Phase 4)Study completedNCT04952766
What this trial is testing

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Who this might be right for
Kidney TransplantMyelomaCancer+6 more
Centre Hospitalier Régional d'Orléans 196
Next Page